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The objectives of this study were to verify the frequency of pharmacological analgesia and the occurrence of
postoperative pain in neonates undergoing cardiac surgery. Methods: This is a cross-sectional study and data
were collected from 30 medical charts of neonates who underwent cardiac surgery in a private hospital in the
city of São Paulo. Results: The majority (96.6%) of neonates received analgesia: 18 (60.0%) received continuous
analgesics, five (16.7%) received intermittent drugs, and six (20.0%) received a combination of continuous
and intermittent analgesics. Fentanyl citrate was continuously administered to 24 (80.0%) neonates. Intermittent
dipyrone and morphine was administered to ten (33.3%) and one (3.3%) neonates, respectively. Pain registers
were observed in 17 (56.7%) medical charts and the occurrence of pain among neonates who received analgesics
was 53.4%. Conclusion: There was no efficacy in pharmacological postoperative pain control in the neonates
included in this study.
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USO DE FÁRMACOS ANALGÉSICOS EN POSTOPERATORIO DE CIRUGÍA
CARDIACA NEONATAL
Los objetivos de este estudio fueron verificar la frecuencia de cobertura analgésica farmacológica y la aparición
de dolor postoperatorio en neonatos sometidos a la cirugía cardiaca. Método: se trata de un estudio transversal
con recolección de datos de Historias Clínicas de 30 neonatos sometidos a cirugía cardiaca en un hospital
privado de la ciudad de San Pablo. Resultados: La frecuencia de cobertura analgésica fue de 96,6%, 18(60,0%)
recibieron analgesia continua, cinco (16,7%) intermitente y seis (20,0%) intermitente y continua. El citrato de
fentanil fue administrado continuamente a 24 (80,0%) neonatos. Dipirona y morfina fueron administradas en
dosis intermitentes a diez (33,3%) y a un (3,3%) neonatos, respectivamente. Fueron identificados registros de
ocurrencia de dolor en 17 (56,7%) Historias Clínicas. La ocurrencia de dolor postoperatorio en recién nacidos
con cobertura analgésica fue 53,4 %. Conclusión: los datos apuntan que el abordaje analgésico adoptado se
mostró ineficaz para controlar el dolor postoperatorio en los neonatos estudiados.
DESCRIPTORES: recién nacido; dolor; analgesia; cardiopatías congénitas
USO DE FÁRMACOS ANALGÉSICOS EM PÓS-OPERATÓRIO DE CIRURGIA
CARDÍACA NEONATAL
Os objetivos deste estudo foram verificar freqüência de cobertura analgésica farmacológica e ocorrência de
dor pós-operatória em neonatos submetidos à cirurgia cardíaca. Método: estudo transversal com coleta de
dados de prontuários de 30 neonatos submetidos à cirurgia cardíaca em um hospital privado da cidade de São
Paulo. Resultados: a freqüência de cobertura analgésica foi de 96,6%, 18(60%) receberam analgesia contínua,
cinco (16,7%) intermitente e seis (20%) intermitente e contínua. O citrato de fentanil foi administrado
continuamente a 24 (80%) neonatos. Dipirona e morfina foram administradas em doses intermitentes a dez
(33,3%) e um (3,3%) neonato, respectivamente. Foram identificados registros de ocorrência de dor em 17
(56,7%) prontuários. A ocorrência de dor pós-operatória em recém-nascidos com cobertura analgésica foi
53,4%. Conclusão: os dados apontam que a abordagem analgésica adotada mostrou-se ineficaz para controlar
a dor pós-operatória nos neonatos estudados.
DESCRITORES: recém-nascido; dor; analgesia; cardiopatias congênitas
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INTRODUCTION
Neonatal period is a phase of intense
adjustment and change in organs and systems,
especially in the circulatory and respiratory system
due to the adjustment to the extrauterine environment.
The occurrence of cardiac malformations makes these
adjustments harder, in addition to contributing to
increase in morbidity and mortality of neonates.
According to the type of abnormality, neonates may
possibly require surgical intervention in the first days
of life to survive.
Surgical procedures to correct cardiac
abnormalities may be complex and lead to severe
postoperative (PO) pain, due to surgical incision and
the extensive maneuver of organs and tissues. In
turn, in the PO period, newborns (NB) undergo several
other invasive and painful procedures such as venous
and artery puncture to collect blood samples, frequent
tracheal aspiration, as well as the devices maintained
such as tracheal canula, drains, vascular catheters,
tenckoff catheter, among others(1), which contributes
to the occurrence of pain.
For these newborns, pain may lead to
tachycardia, resulting in hemodynamic compromising,
supraventricular tachyarrhythmias, and hypertension,
that may cause a critical and intolerable increase in
the ventricular post load(2). It is also known that pain
in the neonatal period may bring future results in
motor, cognitive and affective response and it can
cause changes in the pain threshold and in local
sensibility(3).
Circuits responsible for inhibition and pain
modulation are still immature in NB(4), justifying the
importance of adopting measures to control pain,
especially in the PO period.
Prescribing analgesics is a medical attribution,
however, nurses must offer NB proper control of pain,
which includes not only assessing the pain, but also
assessing the effectiveness of pharmacological
analgesia prescribed and administered. Thus, to know
the types of analgesic employed, the dose, time of
action, metabolism and excretion, the route of
administration, the possible drug interactions, the
adverse effects of analgesic and other medications
adopted by the medical team is a necessary measure.
However, the literature points out that the
prescription of analgesic medication to neonates is
still parsimonious. In a study reviewing charts, it was
assessed that 70.0% of adults received PO analgesia,
and only 30.0% of children (from one day of life to 14
years old) received pharmacological analgesia(5).
Assessment of children’s charts (between zero
and 10 years old) showed that only 2.0% of patients
received all doses prescribed of analgesics during PO(6).
Analysis performed in 933 charts of neonates undergoing
surgical procedures showed the absence of assessment
records of pain and analgesia in 86.0 %(7).
PO analgesia is extremely important to assist
surgical patients(8), including neonates; however,
studies show poor analgesia in the pediatric age
group. Clinical experience with NB undergoing cardiac
surgeries shows that even under the use of
pharmacological analgesia and sedatives given in PO,
signs indicating pain continued.
Such observation encouraged us to make the
present study, whose objectives were: assess
frequency of NB receiving analgesics, identify the
analgesic approach, and check the frequency of painful
response in neonates between the 24th and 47th
complete hours of PO of cardiac surgery.
MATERIALS AND METHODS
Cross-sectional study with retrospective data
collection, performed in a private medium-size
hospital, located in the West side of the city of São
Paulo (SP), and that is a reference in neonatal cardiac
surgery. Data were collected as of the records in charts
of neonates undergoing cardiac surgery from July 2001
to December 2005. Collection and data analysis were
performed from October and December 2005.
Charts of neonates undergoing cardiac
surgery and with gestational age ≥ 35 weeks at birth
were included in the study. We have excluded deaths
in the first 48 hours, and NB with diagnoses of other
malformations besides the cardiac one.
Variables studied were: type of
pharmacological analgesia administered, dose (in
mcg/kg/h or mg/kg/h) administered type of infusion
(continuous or intermittent), assessment of pain, and
diagnoses of pain. Records made between the 24th
and the 47th PO hour were assessed. Records of the
first 24 PO hours have been excluded because of
residual effects of anesthesia used in the surgery.
Data collection was performed as of the
medical prescription and nursing records (prints on
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vital data control and nursing notes). Regarding the
assessment of pain, this process was inserted, in a
systematized fashion, on the Neonatal Intensive Care
Unit of NB in November, 2003. Before that, there was
no standardization regarding assessment of pain in
NB, and the clinical nurse was in charge of prescribing
methods and intervals between pain assessments.
The way records were made was the responsibility of
the nursing team (generally, notes considered some
specific signs as pain indicators, for example crying,
agitation, tight facial muscles, increase in heart rate,
fall in saturation). As of November, 2003, Neonatal
Infant Pain Scale – NIPS(9) started being used for pain
assessment. This is a scale validated in 1993 that
considers the following parameters in the assessment
of pain: facial expression, cry, breathing patterns,
arms, legs, and state of arousal of NB; its score ranges
from 0 to 7 and pain is considered when scores are
higher than 3(9). Additionally, we have adopted specific
paper to record pain and the relief methods employed.
With this, assessment methods have been
standardized, however, intervals between pain
assessments continue to be prescribed according to
the need checked by the clinical nurse.
Later, data was transcribed to the tool
developed for the study, stored in a Microsoft Excel
spreadsheet and assessed by the program Epi-Info,
version 6.4.
Data collection was started after assessment
and approval by the Ethical Research Committee of
the Hospital where the study was conducted.
RESULTS
Forty-two charts from neonates undergoing
cardiac surgery have been identified, 30 of them met
the eligibility criteria of the study. The group studied
presented mean gestational age at birth of 37.64
weeks, with a ± 1.15 standard deviation, and mean
weight at birth was 2885.5 grams, ±573.9 grams. The
majority of neonates (70.0%) underwent surgical
procedure in the first week of life and in 73.3% sternal
surgical incision was performed.
Of the 30 neonates, 29 (96.7%) received
some type of pharmacological analgesia in the period
studied. The use and the way of administering
pharmacological analgesia are presented on Table 1
below.
Table 1 – Forms of administering analgesics prescribed
on the 1st PO. São Paulo, 2001 to 2005
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It is seen that the use of continuous analgesia
prevailed among NB with pharmacologic analgesia,
totaling 24 (80.0%). In the interval from the 24th and
30th hour, 24 (80.0%) neonates received continuous
analgesia; at the end of the period studied, at the
47th hour, frequency decreased to 20 neonates
(66.6%).
Constant doses of fentanyl were administered
to 8 neonates (26.7%), during the period studied; on
the other hand, there was a large variation on the
doses used in 16 neonates (53.3%) during the period
studied, as presented by Figure 1.
Figure 1 – Maximum and minimal doses of fentanyl
citrate in mcg/kg/h, administered in continuous
infusion. São Paulo, 2001 - 2005
Table 2 presents descriptive statistical
analysis of data referring to minimum and maximum
dose of continuous fentanyl citrate.
sesoD naeM naideM edoM mumixaM muminiM -dradnatS noitaiveD
mumixaM 502.3 062.2 0.1 0.9 081.0 016.2
muminiM 390.2 038.1 0.1 8.7 081.0 238.1
Table 2 – Descriptive statistics referring to maximum
and minimum dose of Fentanyl citrate in mcg/Kg/h,
continuously administered. São Paulo, 2001 to 2005.
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Administration of intermittent medication was
seen in 11 NB (36.6%). Ten neonates (33.3%)
received dipyrone and 1 (3.3%) received morphine,
totaling 28 doses of drugs administered intermittently.
Table 3 shows distribution of doses of intermittent
drugs administered to neonates studied.
Table 3 – Distribution of doses of intermittent drugs
administered to neonates, according to intervals, on
the 1st PO. São Paulo, 2001 – 2005
Doses of dipyrone administered were, on
average, of 24.436 mg/kg, with median of 21.730
and standard deviation of 13.920. Minimum dose
administered was 15.620 and maximum dose was
89.280mg/kg. morphine doses administered were
constant, 0.08 mg/Kg/dose.
It is important to stress that among NB
receiving analgesia, 21 (70.0%) also received
sedatives, among them, 21 (70.0%) received
continuous and/or intermittent midazolam, one (3.3%)
received continuous cisatracurium besylate, one
(3.3%) received continuous chlorpromazine
hydrochloride, and one (3.3%) received intermittent
propofol.
Presence of PO pain was assessed using
behavior and physiological indicators and NIPS scale,
alone or together. Table 4 presents distribution of
neonates according to the occurrence of pain and use
of pharmacological analgesia.
Table 4 – Distribution of newborns according to the
occurrence of pain and administration of
pharmacological analgesia. São Paulo, 2001 - 2005
niapfoecnerruccO
ciseglanafoesU
seY oN latoT
N % N % N %
seY 61 4.35 1 3.3 71 7.65
oN 7 3.32 - - 7 3.32
droceroN 6 0.02 - - 6 0.02
latoT 92 7.69 1 3.3 03 001
It is noticed that only 7 NB (23.3%) did not present
pain in the assessment using the scale. One NB (3.3%)
did not receive either continuous or intermittent analgesia
although it presented record of pain.
DISCUSSION
Because of the several deleterious effects
resulting from pain, its treatment during PO of
neonatal cardiac surgery presents extreme clinical
relevance. Adequate control of pain during PO can
reduce morbidity and mortality of neonates
undergoing neonatal cardiac surgeries(10).
Treatment with medication must be based on
doses adjusted according to body weight, maturation,
physiological development, and clinical condition of
neonates(11). Drugs may be continuous or
intermittently administered. Continuous administration
of opioids seems preferred over in bolus
administration, since it reduces variation of serum
concentration of the drug, thus decreasing toxicity
associated with peaks of concentration(11).
Most of the 24 (80.8%) neonates studied
received continuous pharmacological analgesia during
PO periods and, among them, 20 NB (66.6%) received
continuous drugs during the period studied (up to the
47th PO hour). As previously described, PO analgesia
is essential, however, recommendations regarding its
duration in newborns have not been found. The use
of opioids is recommended in neonates in intensive
care undergoing large surgeries, mechanical
pulmonary ventilation, placement of drains or venous
catheters, and in diseases leading to pain, such as
necrotizing enterocolitis(10). However, must be carefully
used and followed-up by continuous monitoring of vital
data(11) in an intensive care environment.
Fentanyl citrate was administered to all 24
newborns receiving continuous medication. This is a
synthesized phenylpiperidine derivative opioid, 80 to
100 times more powerful than morphine(11). It leads
to analgesia by the link with µ receptors that are
specific and are located in brain and spinal regions
involved in the modulation and transmission of pain;
it is extremely fat-soluble and spreads quickly to
tissue making it easier for it to pass through the blood-
brain barrier(12). It presents quick onset, reaching peak
between 5 to 15 minutes, and short half life, between
1 and 2 hours(11).
It is the opioid of choice in pediatrics due to
its large safety margin and the benefits on
hemodynamic stability(13). For this reason,
administration to hemodynamically unstable patients
is suggested(11).
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Recommended doses range from 0.5 to
2mcg/kg/h continuous fentanyl citrate for neonates
in UTIN(1,11). Especially for PO of neonatal cardiac
surgery, doses between 1 and 3 mcg/kg/h are
suggested(10). Data presented on Picture 1 show that
6 NB (20.0%) received minimum doses of fentanyl
citrate between 0.18 and 1 mcg/kg/h, and 5 (16.6%)
maximum doses between 0.18 and 1mcg/kg/h, lower
than those recommended by the literature.
Treatment with fentanyl citrate, however, has
side effects, and among them the following are
highlighted: seizures, difficulty breathing, thoracic
rigidity, hypotension and bradycardia, nausea and
vomiting, decrease in intestinal motility, constipation
and urinary retention(1,11-12). There may also be
physical dependency and neonatal abstinence
syndrome resulting from continuous infusion of the
medication: the employment of fentanyl citrate for
over three days requires gradual decrease of doses
until it is suspended, and the administration of
methadone, a synthesized opioid with properties
similar to those of morphine, which is recommended
if abstinence syndrome occurs.
Intermittent analgesics were administered in
11 neonates (36.6%). The use of dipyrone,
intermittent drug used in 10 (91.0%) of the 11 NB, is
not recommended by the Food and Drug
Administration since 1998*. Clinical studies
recommending the administration of dipyrone and
specific doses for neonate have not been found.
Morphine, described in the literature as the
most commonly used opioid in clinical practice,
probably because it is more familiar to
professionals(11), was administered only to one of the
neonates studied. This opioid also provides analgesia
through the link with µ receptors. It also presents
quick onset, around 5 minutes, and the peak is reached
in 10 to 30 minutes; its half-life ranges from 3 to 8
hours(11). Recommended doses for administration of
intermittent morphine in neonates ranges from 0.05
and 0.1mg/kg(1). Following recommendations, the
neonates of the present study received intermittent
doses of morphine of 0.08mg/kg.
Adverse effects resulting from the
administration of morphine are: difficulty breathing,
central nervous system depression, increase in
intracranial pressure, bradycardia, arrhythmias,
peripheral vasodilation, hypotension, decrease in
gastrointestinal tract motility, constipation, nauseas,
vomiting, biliary tract spasms, release of anti-diuretic
hormone, urinary retention, histamine release,
physical dependency(1,11).
Randomized clinical trials recently
published(14-15) also point out the impairments on
neurological development in preterm newborns
receiving continuous morphine, compared to placebo
or to those receiving it intermittently, results should
be pointed out and show the need for further studies
on the use of morphine in NB.
Although drugs have been administered in
29 NB, 17 (56.7%) of them were in pain. The absence
of protocols and standardization regarding PO
analgesia is evidenced by the several analgesic
schemes adopted, as well as the doses inferior to
those recommended by other studies with neonates,
which can have contributed to the high incidence of
pain despite the use of drugs.
Eight NB (26.7%) received only analgesics,
either continuously or intermittently; the remaining
21 neonates (70.0%) received sedatives associated
with analgesics. Administration of sedatives is
effective as an adjuvant treatment in PO analgesia,
and it should not be replaceable(10). None of the
neonates received only sedatives, and the
administration of sedatives can reduce behavioral
responses resulting from pain which may have
influenced on the assessment of pain performed.
One neonate (3.3%) did not receive any kind
of pharmacological analgesia during PO, not following
formal guidelines(1) that recommend the use of opioids,
especially, morphine and fentanyl citrate.
CONCLUSION
Frequency of the use of analgesics on the 1st
PO was 96.7%. Fentanyl citrate was the most
frequently continuously administered analgesic, and
8 (26.7%) neonates received constant doses during
the 1st PO. Sixteen (53.4%) received doses that
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www.fda.gov/cder/fdama/10898.pdf>.
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ranged from 0.18mcg/kg/h to 9mcg/kg/h. Intermittent
dipyrone was administered to 10 neonates (33.3%)
in doses ranging from 5.62mg/kg to 89.28mg/kg. Only
one NB (3.3%) received intermittent morphine at the
0.08mg/kg dose. Despite the administration of
analgesics, most neonates (56.7%) presented PO pain.
There was no consensus on the medications
administered, as well as the associations and doses
administered at PO of neonatal cardiac surgery.
FINAL CONSIDERATIONS
Fentanyl citrate and morphine are indicated
for analgesia in neonates. Their beneficial effects have
been proved, as well as their short-terms adverse
effects. However, long-term adverse effects from their
use have not been proven yet.
Even though pain causes several deleterious
effects in NB, we must consider the occurrence of side
effects from the medication administered. The impact
of these drugs on several organs and systems of
neonates must be also considered, since they are still
being formed, especially the central nervous system.
Treatment of PO pain in neonates undergoing
cardiac surgery must occur after specific assessment
to check the presence of pain. Specific instruments
(such as NIPS scale, used in the service studied),
physiological and behavior changes that can be related
to pain are important tools for assessment.
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